Clinical Trial

Kaneka Endovascular Embolization and Protection

Study acronym: KEEP
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 7, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-09-28; most recent amendment 2025-10-02.
Status change: Recruiting → Active, Not Recruiting 2025-10-02
Status change: Not Yet Recruiting → Recruiting 2023-03-17
Trial Details
NCT Number NCT05563051
Lead Sponsor Kaneka Medical America LLC
Conditions Aneurysm Cerebral
Enrollment 164 participants
Start Date 2022-12-13
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-07